HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L-646,462, a cyproheptadine-related antagonist of dopamine and serotonin with selectivity for peripheral systems.

Abstract
The selectivity, peripheral vs. central actions, of the antidopaminergic agent L-646,462 was assessed in two ways. First, elevation of prolactin in serum (peripheral) and homovanillic acid in the striatum were measured in rats. L-646,462 was found to have a central/peripheral activity ratio of 143, whereas comparable values derived for haloperidol, metoclopramide and domperidone were 1.4, 9.4 and 1305, respectively. Second, the ID50 values required to block apomorphine-induced emesis in beagles (peripheral receptor-mediated response) were compared with those required to block apomorphine-induced stereotypy (central receptor-mediated response) in rats. Central/peripheral ID50 ratios of 234, 9.2, 129 and 7040 were obtained, respectively, for L-646,462, haloperidol, metoclopramide and domperidone. The selectivity of L-646,462 for peripheral serotonin (5-HT) receptors in rats was determined by measuring its effectiveness in blocking 5-HT-induced paw edema (peripheral response) and 5-hydroxytryptophan-induced head twitch (central response); a ratio of 114 was obtained. This value agrees nicely with the ratio of 143 derived in the rat ( vide supra) for peripheral selectivity for dopamine receptors. L-646,462 is, therefore, selective in vivo, preferentially blocking dopamine and 5-HT receptors located outside the blood-brain barrier. With regard to dopamine-receptors, L-646,462 was about equipotent and more selective than metoclopramide, while being less potent and less selective than domperidone. Unlike metoclopramide or domperidone, L-646,462 also possessed a reasonably potent 5-HT receptor antagonist effect in vivo.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsM Williams, G E Martin, D C Remy, M Hichens, A W Mangel, D A Taylor, G G Yarbrough, R J Bendesky, S W King, J L Robinson
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 229 Issue 3 Pg. 775-81 (Jun 1984) ISSN: 0022-3565 [Print] United States
PMID6547178 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Dopamine Antagonists
  • Receptors, Serotonin
  • Serotonin Antagonists
  • Cyproheptadine
  • Domperidone
  • L 646462
  • Prolactin
  • Haloperidol
  • Metoclopramide
  • Apomorphine
  • Homovanillic Acid
Topics
  • Animals
  • Apomorphine (antagonists & inhibitors)
  • Cyproheptadine (analogs & derivatives, pharmacology)
  • Domperidone (pharmacology)
  • Dopamine Antagonists
  • Gastrointestinal Motility (drug effects)
  • Haloperidol (pharmacology)
  • Homovanillic Acid (metabolism)
  • Male
  • Metoclopramide (pharmacology)
  • Prolactin (blood)
  • Receptors, Serotonin (metabolism)
  • Serotonin Antagonists (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: